Abstracts (poster) - Wissenschaft Online
Abstracts (poster) - Wissenschaft Online
Abstracts (poster) - Wissenschaft Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Harriet Wikman, Michaela Kraemling, Dirk Kemming, Klaus Pantel<br />
Identification of Target Genes in Micrometastatic Lung Cancer<br />
by Methylation Arrays<br />
We have recently identified specific molecular patterns associated with the presence of<br />
disseminated tumor cells (DTCs) in the bone marrow (BM) in patients with primary early<br />
stage lung cancer. We performed a combined expression and copy number (CGH)<br />
profiling of primary lung tumors, and detected five chromosomal regions differentiating<br />
BM-negative from BM-positive patients. Heterozygotic loss of chromosome 4q12-q32 in<br />
BM-positive patients was the most prominent finding. The same loss was also found to<br />
be common in brain metastases from lung cancer patients. The 4q region spanned over<br />
107.1 Mbp and contained 73 differentially expressed genes. In order to narrow down the<br />
potential target gene in this region, a methylation array-screening was performed. 3<br />
lung cancer cell lines showing loss of 4q were treated with 5-aza-2' deoxycytidine, a<br />
demethylating agent. By comparing the mRNA expression of treated and non-treated cell<br />
line one can identify genes silenced through methylation. As a control for cellular stress<br />
a normal bronchial epithelial cell line was used. Treatments were done in triplicate and<br />
RNA was pooled before the competitive hybridization on Agilent 4x44K arrays. All<br />
together 620 genes were found 2-fold up-regulated in at least two of the cancer cell lines<br />
but not in the control cell line. Of these genes 12 are located to the 4q12-q32. 5 genes<br />
were excluded as no expression could be detected in normal lung tissue or no differential<br />
expression could be found between normal and tumor tissue. We are currently mapping<br />
the methylation sites of the 7 remaining potential target genes and will perform MSI-PCR<br />
on primary lung tumors in order to verify the findings and map down the possible target<br />
gene on 4q responsible for the early micrometastatic spread of lung cancer.<br />
contact:<br />
Dr Harriet Wikman<br />
University Medical Center Hamburg-Eppendorf<br />
Intst. Tumor Biology<br />
h.wikman@uke.uni-hamburg.de<br />
Martinistrasse 52<br />
20246 Hamburg (Germany)